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Abstract
Background:  Reverse transcription-polymerase chain reaction (RT-PCR) is a very sensitive
technique to measure and to compare mRNA levels among samples. However, it is extremely
difficult to maintain linearity across the entire procedure, especially at the step of PCR
amplification. Specific genes have been used as baseline controls to be co-amplified with target
genes to normalize the amplification efficiency, but development or selection of reliable controls
itself has created a new challenge.
Results: Here, we describe a new quantitative RT-PCR to compare two mRNA samples directly
without the requirement of synthetic control DNAs for reference. First, chimeric RT primers
carrying gene-specific and universal PCR priming sequences with or without a linker for size
distinction were utilized to generate cDNAs. The size-different cDNAs were then combined in a
single reaction for PCR amplification using the same primer set. The two amplified products were
resolved and detected with gel electrophoresis and fluorescence imaging. Relative abundance of the
two products was obtained after a baseline correction.
Conclusion: This methodology is simple and accurate as indicated by equal amplification efficiency
throughout PCR cycling. It is also easily implemented for many existing protocols. In addition,
parameters affecting RT linearity are characterized in this report.
Background
Many techniques have been developed to quantify mRNA
levels [1]. Among them, reverse transcription-polymerase
chain reaction (RT-PCR), amplifying nucleic acid mole-
cules, is the most sensitive method [2-4]. The amount of
starting mRNA is not only significantly conserved, but
also genes with low expression level are detectable after
amplification. Since the RT-PCR consists of cDNA synthe-
sis, DNA amplification, and signal detection as sequential
steps, the accuracy of quantification is dependent on the
efficiency across these steps, especially the RT and the
cDNA amplification. The difference in product yield due
to varied RT and PCR efficiencies, even though small in
the beginning, can be amplified dramatically to confuse
the final quantification (Fig. 1). Several approaches have
been pursued to overcome this technical limitation.
The relative RT-PCR procedure first establishes a number
of amplification cycles, which is within linear range, and
then compares samples from separate reactions to procure
the ratios [2]. This procedure does not account for the var-
iation among reactions in different PCR environments,
such as specific contents of each tube and difference
between wells of the thermal cycler. Although linearity is
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obtained, the slopes of lines, indicative of efficiency, may
not be equivalent, as seen in Figure 1. Another approach
is to co-amplify control DNAs with target genes in a pro-
cedure termed competitive RT-PCR [3,4]. The diverse effi-
ciencies among PCRs are normalized with a signal of the
same control DNA co-amplified with every test sample. In
order to assure that control DNA gives the same PCR effi-
ciency as the target gene, the control needs to be con-
structed empirically to minimize variation during co-
amplification. To accomplish this, a specific control is
developed for each target gene. Because synthetic con-
trol(s) are often much more abundant than the target,
PCRs of serial dilution of control(s) are carried out to
determine accurately the relative quantity of target to con-
trol(s). These steps complicate the entire procedure and
make the competitive RT-PCR cumbersome. Real-time
RT-PCR, an automatic version of relative RT-PCR, pro-
vides an advantage in that it monitors product yield dur-
ing amplification cycling [4-6]. The CT value, the
minimum number of cycles beyond which the signal
exceeds a predetermined threshold, is commonly used for
quantification, with the assumption of approximately
100% or equal efficiency for all PCR in the early phases of
amplification. Special algorithms are then applied to
obtain the relative quantity. However, the legitimacy of
such assumptions and mathematical models has been
challenged by others [7,8]. Although real-time PCR pro-
vides high-throughput quantification, it is still not acces-
sible to everyone due to the high cost for the equipment,
and it is not cost-effective for projects examining only a
few sample pairs.
A new simple quantitative RT-PCR capable of retaining
the same amplification efficiency between two test sam-
ples throughout the reaction is described here (Fig. 2).
First, size-different cDNAs were generated for later prod-
uct differentiation. The two cDNAs were then combined
in a single amplification reaction with identical PCR
parameters. The efficiency of the RT reaction was also
examined with this new technique. During the course of
Mathematical model of PCR efficiency plot and estimation of original copy number after amplification Figure 1
Mathematical model of PCR efficiency plot and estimation of original copy number after amplification. Accu-
rate estimation can be obtained only when the PCR efficiency is known or is equal between two reactions. Top panel: two PCR 
reactions with the same original copy number but different amplification efficiency (A versus B). Bottom panel: two PCR reac-
tions with different original copy number but the same amplification efficiency C.
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this technical development, we noticed that a commercial
kit has a similar but not identical design, called
comparative RT-PCR [9]. In this study, we also compared
the kit with our methodology.
Results
Constant ratio throughout PCR
The PCR efficiency of different products derived from VHL
gene sequences was tested first. The cDNAs, generated by
corresponding long and short RT chimeric primers from
equal amounts of total RNA, were combined at 1:1 vol-
ume ratio for 25 to 40 cycles of PCR. A consistent relative
intensity of long to short VHL products was obtained
throughout PCR cycling (Fig. 3A). This equal PCR effi-
ciency for the short and long products was also demon-
strated by apparent parallel curves in a log scale plot even
though they were not straight lines (Fig. 3B). Since differ-
ent primers were used in the RT step, deviation of the
observed values from the expected 1:1 ratio was antici-
pated and was dissimilar between two PCR series with dis-
tinct linker sequence, (G)10  versus (C)10  (Fig. 3A).
Permutation of RT parameters, including annealing
Diagram of the new quantitative RT-PCR method Figure 2
Diagram of the new quantitative RT-PCR method.
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temperature, the addition of RNase H, dilution of RNA,
the use of mRNA, and cDNA purification by size-selecting
column, reduces the variability only to a small extent. A
similar picture was seen using other VHL and Collagen I
Observed PCR product ratios (A) and PCR efficiency plots (B) of 1:1 VHL long to short cDNA Figure 3
Observed PCR product ratios (A) and PCR efficiency plots (B) of 1:1 VHL long to short cDNA. The long (with 10-
base G or C linker) and short (VHL-S) cDNAs were synthesized by Thermoscript reverse transcriptase. Weak bands of much 
higher than the correct 123 bp and 113 bp products were single-stranded populations of these two amplicons.
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chimeric primers (data not shown), but the deviation of
the observed ratio from the expected value was higher for
products with a 15-bp difference in length than with 10
bp.
Accurate ratio estimation
Because the observed PCR product ratio for equal vol-
umes of short and long cDNAs, from the same amount of
total RNA, was not equal to 1, serial cDNA ratios were
examined to determine if accurate estimation could be
obtained by a baseline correction. To test if the variation
was contributed by the RT reactions, long and short
cDNAs were pipetted from the same RT reactions to pre-
pare 1:1, 5:1, and 10:1 volume ratios, in which either the
short or the long cDNA is not only a test sample but also
a PCR control. This PCR control functions just like an
external control or competitor in the competitive RT-PCR.
After PCR, the observed ratios were corrected with values
from either 1:1 or 5:1 long to short volume ratios from
corresponding PCR cycles. An example of this experiment,
carried out for sequences from the Collagen I gene, was
illustrated in Figure 4. As seen in Figure 3A above, a close
calculated ratio of long to short product was observed
throughout PCR cycling for each cDNA ratio series (Fig.
4A). The intensity of 25-cycle products was near the back-
ground, which cannot provide accurate quantification,
and therefore the ratio was not calculated. The log plot
also showed a similar PCR efficiency, as evidenced by par-
allel curves, across the amplification cycle within each
series (Fig. 4B). Among series, different efficiency was
noted, especially for early PCR cycles of the 5:1 samples.
When the observed value for 1:1 cDNA ratio was used as
the denominator, the corrected values for 5:1 cDNA were
about 4.0 from triplicate assays and they were consistent
across PCR cycles (p = 0.79, statistical test for difference).
The same consistency was also observed for corrected
ratios for 10:1 cDNA relative to 5:1 cDNA (p = 0.61) and
the values were about 2.0 from three repeated analyses.
This serial experiment showed that baseline normaliza-
tion was very important to correct the inherent RT
variation from use of different primers and two separate
reactions for short and long cDNA production.
Linearity of quantification for known RNA ratios
To investigate linearity of the current quantitative RT-PCR
procedure, cDNAs of the collagen I and the VHL genes
were generated from incremental quantities of total RNA
of the same cell line (0.2 µg, 1 µg, and 2 µg). Equal vol-
umes of these long and short cDNAs were combined to
become 1:1, 5:1, and 10:1 ratios, and were amplified by
25–40 cycles of PCR. At an early stage of this new tech-
nique development, the observed values were never close
to predicted ratios of the RNA samples even after baseline
correction using an AMV (Thermoscript) enzyme in the
RT step. In the "Accurate ratio estimation" experiment
above, the direct quantitative PCR itself gave values very
close to expected ratios. The inability to attain the pre-
dicted RNA ratios is most likely due to non-linear rela-
tionship between RNA input and cDNA yield. Therefore,
several reverse transcriptases, including Thermoscript,
Superscript, Retroscript, and Omniscript, were examined
to determine the efficiency of RT reactions. Initial analyses
following manufacturers' protocols demonstrated that the
new RT-PCR using the Omniscript yielded ratios that are
closest to those predicted (data not shown). The linearity
of quantification for known RNA ratios is illustrated in the
top panel of Figure 5A, in which the corrected ratios for
5:1 and 10:1 RNA for the Collagen I were statistically no
different from the values observed for 5:1 and 10:1 cDNA
in Figure 4A at 35 cycles (p = 0.64 and p = 0.35, respec-
tively) and 40 cycles (p = 0.10 and p = 0.44, respectively).
Notably, the 1:1 RNA for the Collagen I long products
from less than 30-cycle PCR had fluorescence intensity
close to background and the difference in the yield of long
versus short products was very marked throughout (Fig.
5B). These were proven to be the key factors resulting in
variation in ratio estimation, and therefore 2:1 or 5:1 sam-
ples were chosen for use in baseline corrections in the
analyses of cell lines. When additional genes, VHL (Fig.
5A, lower panel) and Tem8 (data not shown), were exam-
ined, the average corrected ratios were close to the
expected values for 5:1 RNA but not for 10:1 RNA, sug-
gesting variability of RT efficiency among target genes and
needs for further RT improvement.
Since the IntraSpec Comparative RT-PCR kit with a similar
but not identical design became commercially available
while we were developing the current technique, the fea-
sibility of the kit for quantification of the VHL and Colla-
gen I RNAs was also determined simultaneously. Analysis
of the rat VHL RNA was excluded because a poly-A tail
could not be found in any rat VHL sequences deposited in
the GenBank. The amplification of Collagen I is shown in
Figure 6. Multiple bands, similar to an artifact when
amplifying repetitive sequences [10], were observed, in
addition to two products with the correct length. Only
products of 35- and 40-cycle PCR were unambiguously
measured by the imaging system. The corrected ratios for
10:1 RNA were 1.0 and 1.4, apparently different from the
expected value, 10, suggesting that this method is unsuit-
able for quantification.
Comparison among cell lines
The new direct quantitative RT-PCR was next applied to
compare cell lines, which had been shown to be signifi-
cantly different with regard to Collagen I RNA level by
cDNA microarray analysis (Mouse GEM I, IncyteGenom-
ics, St. Louis, MO). Twice the amount of the long cDNA as
the short cDNA was intentionally applied to increase the
intensity of the long product after amplification. ThisBMC Biotechnology 2003, 3 http://www.biomedcentral.com/1472-6750/3/22
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Observed and baseline-corrected PCR product ratios (A) and efficiency plots (B) Figure 4
Observed and baseline-corrected PCR product ratios (A) and efficiency plots (B). The 1:1, 5:1, and 10:1 volume 
ratios of long (L) to short (S) Collagen I cDNA synthesized by the Thermoscript reverse transcriptase were examined to deter-
mine the accuracy of corrected ratios (with value from either 1:1 or 5:1 ratio of corresponding PCR cycle as the denominator) 
to expected values.
1:1 cDNA       5:1 cDNA       10:1 cDNA
25  30  35  40  25  30  35  40  25  30  35  40
L/S  0.29 0.33 0.35     1.26 1.17 1.12  2.65 2.34 2.23
5:1/1:1  4.3   3.5   3.2
Triplicate (p=0.79)             4.0   4.1   3.7
±0.4 ±1.0 ±0.6
10:1/5:1                                                    2.1   2.0   2.0
Triplicate (p=0.61)  2.3  2.1  2.2
±0.4 ±0.1 ±0.2
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Observed and baseline-corrected ratios of long (L) to short (S) Collagen I and VHL PCR products Figure 5
Observed and baseline-corrected ratios of long (L) to short (S) Collagen I and VHL PCR products. The cDNAs 
were synthesized by Omniscript reverse transcriptase from incremental quantities of total RNA (A). The observed ratios were 
corrected by values from either 1:1 or 5:1 RNA ratio of the corresponding PCR cycle. PCR efficiency plot is illustrated for Col-
lagen I only (B).
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Col-L/Col-S   0.21  0.16  0.11     0.58  0.55  0.53  1.05  1.11  1.27
5:1/1:1  2.8  3.4    4.8
Quadruplicate  2.9 3.8 4.5
±0.3  ±0.6  ±0.5
10:1/5:1                                    1.8  2.0    2.4
Quadruplicate  1.7    1.9  2.1
±0.1  ±0.2  ±0.3
VHL-L/VHL-S   
0.38  0.32 0.30 0.27 1.35 1.40 1.35 1.26 1.98 1.93 1.82 1.77
5:1/1:1  3.6  4.4   4.5   4.7
Triplicate  2.9  3.4   3.6  3.7
±0.4  ±0.9 ±0.8 ±0.9
10:1/5:1                                                     1.5  1.4  1.3   1.4
Triplicate                                             1.4   1.4   1.4   1.4
±0.1 ±0.2 ±0.2 ±0.2
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practice did not change the final calculation; rather, it
improved the ratio estimation, especially for long prod-
ucts below detectable level by computer-assisted software
(data not shown). The observed and corrected ratios for
cell lines 4N versus 6N, NRK versus 4N, and NRK versus
6N are illustrated in Figure 7. For each pair, four observed
ratios of long to short products, including two for baseline
correction and two of crude ratio between cell lines, were
used to cross-check the accuracy of final quantification. In
repeated experiments, the ratios of 6N over 4N (6N-L/4N-
L or 6N-S/4N-S) and NRK over 4N (NRK-L/4N-L or NRK-
S/4N-S) using either of the corresponding baseline
estimators (4N-L/4N-S or 6N-L/6N-S; NRK-L/NRK-S or
4N-L/4N-S) were statistically not different within the
group (p = 0.85 and p = 0.40, respectively). This similar
two-fold up-regulation of the Collagen I in 6N and NRK
over 4N was further confirmed by a direct comparison
between 6N and NRK, which showed an equal level of
expression (right panel, Fig. 7). The Collagen I ratios of 6N
over 4N and NRK over 4N from microarray analysis were
equal or higher than 1.7, the lower end of ratio differences
regarded as likely significant by IncyteGenomics. Thus,
this new RT-PCR technique is very reliable for confirming
microarray results.
Discussion
To achieve accuracy of quantification for RNA transcripts
requires the acquisition of reaction and detection linearity
throughout the entire procedure. Since the first develop-
ment of RT-PCR, numerous approaches have been formu-
lated to improve the precision of protocols from RNA
measurement, RT, PCR, signal detection and analysis, to
final mathematical correction. In this study, we have
explored many aspects of quantitative RT-PCR with
emphases on the RT and PCR steps. Accuracy is enhanced
by improving the linearity of the RT reactions and by elim-
inating variations among PCR reactions (exemplified in
Figs. 4B and 5B for efficiency), as well as sample loading
for gel electrophoresis since two samples were co-exam-
ined during these analyses. Although competitive RT-PCR
Observed and baseline-corrected ratios of long to short Collagen I PCR products Figure 6
Observed and baseline-corrected ratios of long to short Collagen I PCR products. The cDNAs were synthesized by 
an IntraSpec kit from incremental quantities of total RNA. The proper product sizes were 222 bp and 182 bp.
1:1 RNA                 10:1 RNA
25    30    35    40    25    30  35  40
Marker
222 bp
182 bp
234 bp
194 bp
222-bp/182-bp        1.02   0.69  1.05   0.98
10:1/1:1                                                     1.0 1.4 BMC Biotechnology 2003, 3 http://www.biomedcentral.com/1472-6750/3/22
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also provides such advantages, quantification with the lat-
ter technique is complicated by the need of reliable
controls and for accurate estimation. Also, these controls
are usually purified RNA or DNA, which are much more
abundant than the target sequences in the cell sample.
Serial dilution of controls is required for competitive RT-
PCR. The unique designs in the new technique, such as
gene-specific RT primers, a linker of either 10 or 15 bases
in the long RT primer, and co-purification of cDNAs gen-
erated from the short and long RT primers, are different
from the Ambion IntraSpec kit and are apparently impor-
tant innovations to obtain specific amplification and
accurate quantification. The strengths of this new quanti-
tative RT-PCR include: it is a direct comparison of two
RNA samples with no need of synthetic control(s); it is
simple with no complex issues arising from the use of syn-
thetic control(s); and it is accurate. Although a slight vari-
ation of ratio estimation utilizing 1:1 volume ratio of long
to short product from the same RNA for baseline correc-
tion is seen, this can be highly reduced by the use of 5:1
(Figs. 4 and 5) or 2:1 (Fig. 7) for correction. Up to 1 order
of magnitude of the dynamic range has been accurately
obtained using the new method. Further analyses for
Application of the new quantitative RT-PCR to determine the ratios of gene expression among cell lines Figure 7
Application of the new quantitative RT-PCR to determine the ratios of gene expression among cell lines. The 
Collagen I cDNAs were synthesized by Omniscript reverse transcriptase. The observed 35-cycle values of long (L) over short 
(S) PCR products from different sample combinations were used for calculation of corrected ratios. 4N: wild-type VHL-trans-
fected NRK; 6N: mutant VHL-transfected NRK.
Marker
122 bp
107 bp
200 bp
100 bp
L/S   0.44  0.94  0.20  0.34  0.59  0.27  1.56  0.59                0.59  0.60  0.56  0.56
4N-L/4N-S
6N-L/4N-S
4N-L/6N-S
6N-L/6N-S
NRK-L/NRK-S
4N-L/NRK-S
NRK-L/4N-S
4N-L/4N-S
Corrected ratios:
6N-L/4N-L= 0.94/0.44= 2.1 or 0.34/0.20= 1.7           NRK-L/6N-L= 0.59/0.60= 1.0 or 
Triplicate for 6N-L/4N-L: 2.3±0.2 or 2.2±0.5                                  =0.56/0.56= 1.0
6N-S/4N-S= 0.44/0.20= 2.2 or 0.94/0.34= 2.8 
Triplicate for 6N-S/4N-S: 2.3±0.7 or 2.3±0.7
NRK-L/4N-L= 0.59/0.27= 2.2 or 1.56/0.59= 2.6      NRK-S/6N-S= 0.56/0.60= 0.9 or
Duplicate for NRK-L/4N-L: 1.9±0.4 or 2.2±0.6                              = 0.56/0.59= 0.9
NRK-S/4N-S= 1.56/0.59= 2.6 or 0.59/0.27= 2.2
Duplicate for NRK-S/4N-S: 2.6±0.0 or 2.3±0.1
NRK vs. 4N
4N vs. 6N
NRK-L/NRK-S
6N-L/NRK-S
NRK-L/6N-S
6N-L/6N-S
NRK vs. 6NBMC Biotechnology 2003, 3 http://www.biomedcentral.com/1472-6750/3/22
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higher ratio differences are needed to establish the upper
limit of dynamic range for this method.
The accuracy of this direct quantitative RT-PCR is also
demonstrated in the comparison of the Collagen I expres-
sion among three cell lines (Fig. 7). Inclusion of 4 reac-
tions for each pair is useful for cross validation of the
corrected ratio. In general, two reactions, one for baseline
correction and one of crude ratio between samples, are
sufficient to determine the final ratio.
Although the new technique measures only relative
amounts of RNA in the two samples, an absolute copy
number can be calculated from a calibration curve of ref-
erence DNA with the same sequence and length loaded
onto the same gel. Reference DNA can be generated by
PCR and purified in large quantity, and the copy number
is then estimated from the absorbance at 260 nm wave-
length. The new technique can also be modified to use
regular polyT as a RT primer to produce cDNAs for subse-
quent PCR of more than one gene. We have synthesized
chimeric primers to generate first-strand short and long
DNA from corresponding polyT-cDNAs. The two first-
strand DNAs are combined and are analyzed as in the
present protocol. Although the current version of this new
methodology is not suitable for high throughput gene
expression profiling, we are currently investigating the
possibility of converting this direct quantitative RT-PCR
into a real-time format. With this innovation, no multiple
PCR with incremental cycles is needed to determine the
minimal number of cycles. Signal acquisition, graphic
plotting, and baseline correction can be streamlined by
any real-time analyzer with sophisticated software.
Conclusions
A direct quantitative RT-PCR (Fig. 2) has been described
to obtain accurately the ratio of gene expression among
samples. Approaches to reduce analytical variation
throughout the entire RT-PCR procedure have been also
presented here in detail.
Methods
RNA
Trizol reagent was used to extract total RNA from a NRK-
52E rat kidney cell line and its daughter lines [11],
according to the manufacturer's direction with some mod-
ifications (Life Technologies, Gaithersburg, MD). In brief,
cells were cultured in Dulbecco's modified Eagle's
medium (Biofluids, Rockville, MD) supplemented with 4
mM L-glutamine, 5% calf serum, 100 unit/ml penicillin,
and 100 µg/ml streptomycin, in 3 T-162 flasks until they
reached confluence. After removal of the media, 15 ml Tri-
zol reagent was added directly into the first flask and then
transferred sequentially to the second and the third flasks.
The 15 ml lysate was held for 15 minutes at room temper-
ature before the addition of 3 ml chloroform and vigorous
shaking for 15 seconds. Phase separation of organic and
aqueous layers was accelerated by centrifugation at
>12,500 × g for 15 minutes at 4°C. The upper aqueous
phase was transferred into a new tube and 8 ml isopropa-
nol was added, followed by centrifugation at 14,000 × g
for 15 minutes to precipitate RNA. The pellet was dis-
solved in RNase-free water. The total RNA was quantified
by a spectrophotometer (8452A, Hewlett Packard, Missis-
sauga, Canada) at 260 nm and was then verified with a
RiboGreen RNA quantitation kit following the manufac-
turer's instruction (Molecular Probes, Eugene, OR). The
RiboGreen fluorescence binds efficiently to single-
stranded nucleic acids without interference from proteins
and remnants of RNA extraction reagents, if present, in
RNA solution. Ribosomal RNA was provided in the kit for
generation of a standard curve, which was then used for
sample quantity estimation.
RT-PCR
The direct quantitative RT-PCR method is outlined sche-
matically in Figure 2. An Avian Myeoblastomosis virus
(AMV) reverse transcriptase without RNase H activity
(Thermoscript, Invitrogen, Carlsbad, CA), Moloney
Murine Leukemia virus (MMLV) reverse transcriptase
without RNase H activity (Superscript II, Invitrogen; Ret-
roscript, Ambion, Austin, TX), or a new reverse tran-
scriptase retaining the RNase H activity (Omniscript,
Qiagen Inc., Valencia, CA) was used to generate cDNA
strands following each supplier's protocol. Briefly, RT was
carried out in a 20 µl mixture including 0.5 µM gene-spe-
cific chimeric primer and 200 ng to 2 µg total RNA. The RT
chimeric primer consists of a gene-specific and a universal
sequence with or without 10- or 15-base linkers (Table 1).
Oligo software (version 5, National Biosciences, Inc., Ply-
mouth, MN) was utilized to assist the primer selection
[12]. The universal sequence was manually composed and
did not match any sequences in the GenBank. This
sequence was specifically recognized by the lower PCR
primer during amplification. The reaction was performed
at 55 to 65°C (for Thermoscript), 42°C (for Superscript II
and Retroscript), or 37°C (for Omniscript) for 1 hour and
was stopped by heat inactivation of the enzyme, as
described by the manufacturers.
An aliquots of the short and long cDNAs were combined
directly for purification with a Microcon 50 size-fraction
spin column (Millipore, Bedford, MA) to remove RT
primers before PCR. A Platinum Taq polymerase kit for
hot start PCR was used according to the manufacturer's
instruction (Invitrogen). Briefly, PCR was carried out in a
mixture of 20 mM Tris-HCl, pH 8.0, 50 mM KCl, 0.2 mM
deoxynucleotides, 1.5 mM MgCl2, 0.2 µM of each primer,
and 2 U Platinum Taq DNA polymerase. The PCR thermal
control started at 94°C for 2 minutes initially to activateBMC Biotechnology 2003, 3 http://www.biomedcentral.com/1472-6750/3/22
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HotStart Platinum polymerase, followed by cycling of
94°C for 30 sec., 60°C for 30 sec., and 68 (or 72) °C for
1 minute for 25 to 40 times.
The amplified short and long products with 10 and 15
base-pair (bp) difference in length were resolved in 20%
and 10% polyacrylamide gel (Invitrogen), respectively.
The gel was then stained with SYBR Green I fluorescence
(Molecular Probes). Fluorescence signal was detected and
analyzed by a BioChemi imaging system equipped with
LabWorks 4.0 software (UVP Inc., Upland, CA). Initial
measurement using "area density" function, which
requires manually bracketing product bands, did not give
a consistent quantification from the same products. A
function with computer-assisted band identification and
integration of peak area capabilities was finally utilized to
obtain fluorescence intensity and the ratio between short
and long product from the same reaction. Log scale of flu-
orescence intensity was plotted against PCR cycle number
to determine the amplification efficiency.
Quantification using a commercial comparative RT-PCR
kit, IntraSpec, was performed according to the manufac-
turer's instruction (Ambion). The RT primers, Tag10 and
Tag50, with 40-bp difference in length were provided and
were designed to recognize the polyA tail of mRNA. RT
reaction was carried out at 49°C for 2 hours. After purifi-
cation of the Tag10 and Tag50 cDNAs by a DNA-binding
spin column, the two cDNAs were combined in a single
PCR using the lower primer provided in the kit and an
upper primer, which was selected following the manufac-
turer's guidelines. The PCR was conducted as described
above except the annealing temperature was reduced to
50°C.
Statistical analysis
The ratios of repeated experiments were expressed as
mean ± standard deviation. The consistency of mean
ratios among experiments with different permutations,
such as PCR cycles and the choice of baseline correction,
were tested by ANOVA using the StatView software (Ver-
sion 4.5, Abacus Concepts, Berkeley, CA). Mean ratios
were considered to be not different if the p value was
higher than 0.05.
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